NACA
Nascent polypeptide-associated complex subunit alpha, muscle-specific form
Also known as: NACA1, NACAM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- E9PAV3
- Gene
- NACA
- Ensembl
- ENSG00000196531
- Chromosome
- 12
- Canonical length
- 2078 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a protein that associates with basic transcription factor 3 (BTF3) to form the nascent polypeptide-associated complex (NAC). This complex binds to nascent proteins that lack a signal peptide motif as they emerge from the ribosome, blocking interaction with the signal recognition particle (SRP) and preventing mistranslocation to the endoplasmic reticulum. This protein is an IgE autoantigen in atopic dermatitis patients. Alternative splicing results in multiple transcript variants, but the full length nature of some of these variants, including those encoding very large proteins, has not been determined. There are multiple pseudogenes of this gene on different chromosomes. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
2078 residues, UniProt reviewed canonical sequence.
>E9PAV3|NACA
1 MPGEATETVP ATEQELPQPQ AETAVLPMSS ALSVTAALGQ PGPTLPPPCS PAPQQCPLSA
61 ANQASPFPSP STIASTPLEV PFPQSSSGTA LPLGTAPEAP TFLPNLIGPP ISPAALALAS
121 PMIAPTLKGT PSSSAPLALV ALAPHSVQKS SAFPPNLLTS PPSVAVAESG SVITLSAPIA
181 PSEPKTNLNK VPSEVVPNPK GTPSPPCIVS TVPYHCVTPM ASIQSGVASL PQTTPTTTLA
241 IASPQVKDTT ISSVLISPQN PGSLSLKGPV SPPAALSLST QSLPVVTSSQ KTAGPNTPPD
301 FPISLGSHLA PLHQSSFGSV QLLGQTGPSA LSDPTVKTIS VDHSSTGASY PSQRSVIPPL
361 PSRNEVVPAT VAAFPVVAPS VDKGPSTISS ITCSPSGSLN VATSFSLSPT TSLILKSSPN
421 ATYHYPLVAQ MPVSSVGTTP LVVTNPCTIA AAPTTTFEVA TCVSPPMSSG PISNIEPTSP
481 AALVMAPVAP KEPSTQVATT LRIPVSPPLP DPEDLKNLPS SVLVKFPTQK DLQTVPASLE
541 GAPFSPAQAG LTTKKDPTVL PLVQAAPKNS PSFQSTSSSP EIPLSPEATL AKKSLGEPLP
601 IGKPASSMTS PLGVNSSASV IKTDSYAGPD SAGPLLKSSL ITPTVAAFPL ESADPAGVAP
661 TTAKGTSTYT TTASPFLEGT VSLAPKNHPV KEGTLTTLPL VPTASENCPV APSPQNTCAP
721 LATLVLAPEI PKSVPSPSLP PAGTPPGTKK VDGISHTSAL APVASSPKEC PTEDSGASAT
781 ASSKGTLTYL ADSPSPLGVS VSPQTKRPPT KKGSAGPDTP IGNLSSPVSP VEASFLPENS
841 LSFQGSKDSP ATTHSPTPPS PKGAPTPSAV TPLSPKGVTL PPKETPTPSV VNLPFPKEGP
901 ATPAPKQAPA LSMTSSSPKK ARATPAPKGI PASPSPKGAP TPPAATPPSP KGGPATPSPK
961 WAPTPPAATP PSPKGGPATP SPKGAPTPPA ATPPSPKGGP ATPSPKGAPT PPAVTPPSPK
1021 GSPAATPFPK GASTPPAATP PSPKGSPAAT PLPKGAPTTP AATLPSPKGG PATPSLKGAP
1081 TPPAATPPSP KGGPATPSPK GAPMPPAATP PSPKGGLATP PHKGAPTTPA ATPPSPKGGL
1141 ATPPPKGAPT TPAATPPSPK GGLATPPPKG APTTPAATPP SPKGGLATPS PKGAPTTPAA
1201 TPPSPKGGLA TPSPKGAPTT PAATPPSPKG GLATPSPKGA PTTPAATPPS PKGGPATPPP
1261 KGAPTPPAAT PPSLKGGLAT PPHKGAPNPA VVTPPSPKGG PATSPPKGAP TPPAATPPSP
1321 KGSPGTPPPK GAPTPPAVTP PSPKGTPTLP ATTPSSKGGP TTPSSKEGPT PPAATPSHKG
1381 GPAMTPPSPK RGPAIPSPKG DPTSPAVIPL SPKKAPATPV TREGAATPSK GDLTPPAVTP
1441 VSLKKAPATS APKGGPATPS SKGDPTLPAV TPPSPKEPPA PKQVATSSSP KKAPATPAPM
1501 GAPTLPAVIP SSPKEVPATP SSRRDPIAPT ATLLSKKTPA TLAPKEALIP PAMTVPSPKK
1561 TPAIPTPKEA PATPSSKEAS SPPAVTPSTY KGAPSPKELL IPPAVTSPSP KEAPTPPAVT
1621 PPSPEKGPAT PAPKGTPTSP PVTPSSLKDS PTSPASVTCK MGATVPQASK GLPAKKGPTA
1681 LKEVLVAPAP ESTPIITAPT RKGPQTKKSS ATSPPICPDP SAKNGSKGPL STVAPAPLLP
1741 VQKDSSKTAK GKDASHSPKG PLAPPESKAS TPLTAAAFEK VLPKPESASV SAAPSPPVSL
1801 PLAPSPVPTL PPKQQFLPSS PGLVLESPSK PLAPADEDEL LPLIPPEPIS GGVPFQSVLV
1861 NMPTPKSAGI PVPTPSAKQP VTKNNKGSGT ESDSDESVPE LEEQDSTQAT TQQAQLAAAA
1921 EIDEEPVSKA KQSRSEKKAR KAMSKLGLRQ VTGVTRVTIR KSKNILFVIT KPDVYKSPAS
1981 DTYIVFGEAK IEDLSQQAQL AAAEKFKVQG EAVSNIQENT QTPTVQEESE EEEVDETGVE
2041 VKDIELVMSQ ANVSRAKAVR ALKNNSNDIV NAIMELTMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NACA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 2,306 nTPM
Expression across tissuesHPA
Tissue
- ovary: 2,306 nTPM
- skin: 1,619 nTPM
- cervix: 1,485 nTPM
- esophagus: 1,459 nTPM
- bone marrow: 1,437 nTPM
- vagina: 1,412 nTPM
Single-cell type
- esophageal apical cells: 7,147 nCPM
- esophageal suprabasal cells: 5,431 nCPM
- esophageal basal cells: 4,476 nCPM
- extravillous trophoblasts: 3,610 nCPM
- decidual stromal cells: 3,565 nCPM
- breast secretory cells: 2,908 nCPM
Immune cell
- total PBMC: 1,953 nTPM
- non-classical monocyte: 1,852 nTPM
- intermediate monocyte: 1,373 nTPM
- plasmacytoid DC: 1,086 nTPM
- myeloid DC: 1,009 nTPM
- classical monocyte: 989 nTPM
Brain region
- spinal cord: 344 nTPM
- white matter: 323 nTPM
- hypothalamus: 302 nTPM
- medulla oblongata: 287 nTPM
- cerebellum: 259 nTPM
- pons: 256 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- -1.28
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NACA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NACA as an antibody target. Whether an autoantibody or antibody against NACA could matter depends on whether native NACA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NACA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- This protein is an IgE autoantigen in atopic dermatitis patients.
Loading the interactive Seroatlas protein explorer...